We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluation of Effectiveness of Treatment Paradigm for Newly Diagnosed Type 2 Diabetes Patients in China (NEW2D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01525693
Recruitment Status : Unknown
Verified February 2012 by China Cardiometabolic Registries.
Recruitment status was:  Active, not recruiting
First Posted : February 3, 2012
Last Update Posted : February 15, 2013
Bristol-Myers Squibb
VitalStrategic Research Institute
Information provided by (Responsible Party):
China Cardiometabolic Registries

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2013
  Estimated Study Completion Date : January 2014